Immunologic Markers for the Differential Diagnosis Between Uveitis-TBC and Uveitis-SARC (TBC-SARC)

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

November 15, 2019

Study Completion Date

December 30, 2022

Conditions
Uveitis TuberculousUveitis Sarcoid
Interventions
DIAGNOSTIC_TEST

Analysis of aqueous humor and plasma samples

"The collected samples will be analyzed as follow:~1. Determination of the concentration of various cytokines, chemokines and groeth factors in aqueous humor and in the plasma.~2. Analysis of the mononuclear cells ( T helper lymphocytes CD3+ and CD4+, T cytotoxic lymphocytes CD3+ CD8+, B lymphocytes CD19+, Natural killer lymphocytes CD56+ and CD3- and monocytes CD14+) present in the aqueous humor by cytofluorimetry.~3. Evaluation of the presence of anti-human HSP70 antibodies in plasma samples by Western blot immunoprecipitation assays.~4. Whenever possible (adequate number of cells), in vitro stimulation of mononuclear cells presence in aqueous humor with epitopes from tuberculosis mycobacterium antigens and the analysis of cytokines production in the supernatants."

Trial Locations (1)

42123

IRCCS/AUSL Reggio Emilia Hospital, Reggio Emilia

All Listed Sponsors
lead

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

NCT03346018 - Immunologic Markers for the Differential Diagnosis Between Uveitis-TBC and Uveitis-SARC (TBC-SARC) | Biotech Hunter | Biotech Hunter